These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12550799)

  • 41. Influence of water-cellulose binding energy on stability of acetylsalicylic acid.
    Heidarian M; Mihranyan A; Strømme M; Ek R
    Int J Pharm; 2006 Oct; 323(1-2):139-45. PubMed ID: 16854539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thermally induced denaturation of lyophilized bovine somatotropin and lysozyme as impacted by moisture and excipients.
    Bell LN; Hageman MJ; Muraoka LM
    J Pharm Sci; 1995 Jun; 84(6):707-12. PubMed ID: 7562408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
    Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
    Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ¹³C solid-state NMR analysis of the most common pharmaceutical excipients used in solid drug formulations, Part I: Chemical shifts assignment.
    Pisklak DM; Zielińska-Pisklak MA; Szeleszczuk Ł; Wawer I
    J Pharm Biomed Anal; 2016 Apr; 122():81-9. PubMed ID: 26845204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of presence of excipients in drug analysis in fed-state gastric biorelevant media.
    Baxevanis F; Kuiper J; Fotaki N
    Eur J Pharm Biopharm; 2018 Oct; 131():178-188. PubMed ID: 30110669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices.
    Levina M; Rajabi-Siahboomi AR
    J Pharm Sci; 2004 Nov; 93(11):2746-54. PubMed ID: 15389670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.
    Miller DP; Lechuga-Ballesteros D
    Pharm Res; 2006 Oct; 23(10):2291-305. PubMed ID: 16955371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are Excipients Inert? Phenytoin Pharmaceutical Investigations with New Incompatibility Insights.
    Amaral Silva D; Löbenberg R; Davies NM
    J Pharm Pharm Sci; 2018; 21(1s):29745. PubMed ID: 29702046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The solution, solid state stability and kinetic investigation in degradation studies of lercanidipine: study of excipients compatibility of lercanidipine.
    Parmar N; Amin S; Singla N; Kohli K
    Pharm Dev Technol; 2012; 17(6):730-40. PubMed ID: 21599490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J; Chan HK; Gengenbach T; Denman JA
    Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets.
    Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS
    Eur J Pharm Biopharm; 2009 Nov; 73(3):404-13. PubMed ID: 19631740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of physical mixtures and directly compressed tablets of sulfamerazine polymorphs: implications on in vitro release characteristics.
    Roy S; Alexander KS; Riga AT; Chatterjee K
    J Pharm Sci; 2003 Apr; 92(4):747-59. PubMed ID: 12661061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
    Wu Y; Dali M; Gupta A; Raghavan K
    Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystallization of excipients in tablets.
    Ando H; Watanabe S; Ohwaki T; Miyake Y
    J Pharm Sci; 1985 Feb; 74(2):128-31. PubMed ID: 3921688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new approach to accelerated drug-excipient compatibility testing.
    Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE
    Pharm Dev Technol; 2003; 8(2):119-26. PubMed ID: 12760562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques.
    Veras KS; Fachel FNS; Pittol V; Garcia KR; Bassani VL; Dos Santos V; Henriques AT; Teixeira HF; Koester LS
    Saudi Pharm J; 2019 Dec; 27(8):1138-1145. PubMed ID: 31885473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physiochemical interactions of praziquantel, oxamniquine and tablet excipients.
    Prankerd RJ; Ahmed SM
    J Pharm Pharmacol; 1992 Mar; 44(3):259-61. PubMed ID: 1354736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.